Mylan NV and Teva Pharmaceutical Industries Ltd decline as report says generic-drug companies face probe of alleged price fixing
![NY AG Letitia James Accuses Teva Pharmaceuticals of Lies and Cover-Up in Opioid Case - Jewish Business News NY AG Letitia James Accuses Teva Pharmaceuticals of Lies and Cover-Up in Opioid Case - Jewish Business News](https://media.jewishbusinessnews.com/2022/07/12114157/NY-AG-Letitia-James-Wikipedia.jpg)
NY AG Letitia James Accuses Teva Pharmaceuticals of Lies and Cover-Up in Opioid Case - Jewish Business News
![$41B for Allergan's generics business? Investors now say Teva 'grossly' overpaid: FT | Fierce Pharma $41B for Allergan's generics business? Investors now say Teva 'grossly' overpaid: FT | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/2016-06/teva1.jpg?VersionId=TdxPbPad17K4AdNXBhnNKb718L2n4FzW)
$41B for Allergan's generics business? Investors now say Teva 'grossly' overpaid: FT | Fierce Pharma
![Teva, Valeant price-hike plans trigger warnings under California's new transparency law: report | Fierce Pharma Teva, Valeant price-hike plans trigger warnings under California's new transparency law: report | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1522677864/Flag-of-California.jpg?VersionId=XLMiA0EuYYxqseCoz9TFede6yg08GXnr)
Teva, Valeant price-hike plans trigger warnings under California's new transparency law: report | Fierce Pharma
![Johnson & Johnson scores an FDA first with nod for twice-yearly schizophrenia drug Invega Hafyera | Fierce Pharma Johnson & Johnson scores an FDA first with nod for twice-yearly schizophrenia drug Invega Hafyera | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1630434478/JNJIOffice3.jpg/JNJIOffice3.jpg?VersionId=nurdJ1vRC3EwUeHXMxrqSQwT9l6XtGwu)